Cancer Research
Turin Study Maps Why Multiple Myeloma Escapes Anti-CD38 Immunotherapy
Italian researchers track genomic and cellular changes in myeloma patients to uncover why anti-CD38 treatments stop working.
Clinical Trial
Jun 16, 2026 0
Cancer
86 articles in this topic
Cancer Research
Phase II Trial Pits Dual Checkpoint Blockade Against Ipilimumab Alone in Advanced Melanoma
NCI-sponsored trial tests whether adding nivolumab to ipilimumab improves outcomes in stage III/IV unresectable melanoma.
Clinical Trial
Jun 16, 2026 0
Cancer Research
AI-Guided Cancer Care Program Targets Immunotherapy Gaps in Minority NSCLC Patients
A Columbia University trial tested a digital care service to improve immunotherapy outcomes and reduce healthcare burden for minority lung cancer patients.
Clinical Trial
Jun 15, 2026 0
Cancer Research
MOBIDERM Compression Panty Tested for Pelvic and Genital Lymphedema Relief
A completed exploratory trial evaluates whether a specialized compression garment can reduce discomfort and improve quality of life in pelvic lymphedema patients.
Clinical Trial
Jun 14, 2026 0
Cancer Research
Trial Tests Whether Stopping Immunotherapy Early Harms NSCLC Patients Who Respond
A randomized Phase 2 trial investigates whether PD-1 inhibitor discontinuation after early response is safe in non-small cell lung cancer.
Clinical Trial
Jun 14, 2026 0
Cancer Research
Belantamab Mafodotin Combos Show Promise in Relapsed Multiple Myeloma Trial
GSK's Phase 1/2 trial tests belantamab mafodotin paired with standard regimens in patients who failed prior myeloma therapy.
Clinical Trial
Jun 9, 2026 0
Cancer Research
ISB 1442 Trial for Relapsed Multiple Myeloma Terminated Early
A first-in-human Phase 1/2 trial of ISB 1442 in relapsed/refractory multiple myeloma was halted before completion.
Clinical Trial
Jun 9, 2026 0
Cancer Research
CD226 Immune Receptor Explored as Predictor of Immunotherapy Response in Advanced Liver Cancer
A French trial investigated whether circulating immune cell profiles, specifically CD226 expression, could predict who responds to Atezolizumab/Bevacizumab in advanced HCC.
Clinical Trial
Jun 9, 2026 0
Cancer Research
Metronomic Vinorelbine Plus Atezolizumab Tested as Second-Line NSCLC Therapy
A completed Phase 2 trial explores whether low-dose continuous chemotherapy can boost immunotherapy efficacy in advanced lung cancer.
Clinical Trial
Jun 9, 2026 0
Cancer Research
Combo Immunotherapy Plus Liver Embolization Targets Metastatic Uveal Melanoma
A phase II trial tests ipilimumab and nivolumab paired with immunoembolization against liver-spread uveal melanoma.
Clinical Trial
Jun 6, 2026 0
Cancer Research
Skin Microbiome Shifts Detected in Immunotherapy Rash Patients
A City of Hope study explores whether skin bacteria differ between rash-affected and healthy skin in cancer immunotherapy patients.
Clinical Trial
Jun 6, 2026 0
Cancer Research
Phase I Trial Tests Triple Drug Combo for BRAF-Mutant Metastatic Solid Tumors
MD Anderson researchers evaluated vemurafenib, cetuximab, and irinotecan together to find the optimal dose and safety profile for advanced solid tumors.
Clinical Trial
Jun 5, 2026 0